Autobio Diagnostics Co., Ltd. Announces Earnings Guidance for the Year 2018
January 29, 2019
Share
Autobio Diagnostics Co., Ltd. announced earnings guidance for the year 2018. The Company predicts an increase of between RMB 89,312,800 and RMB 156,297,500 in its net profit owned by shareholders of the listed company compared with the same period of the year before, with a year-on-year increase of between 20% and 35%. The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will increase by between RMB 82,881,300 and RMB 145,042,300 compared with the same period of the year before, with a year-on-year increase of between 20% and 35%.
Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.